BIOCHEMICAL AND RADIOGRAPHIC RESPONSE TO ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITHOUT PREVIOUS CHEMOTHERAPY

被引：0
|
作者：
Poti, Giulia [1 ]
Giacinti, Silvana [1 ]
Macrini, Serena [1 ]
Bassanelli, Maria [1 ]
Roberto, Michela [1 ]
Aschelter, Anna Maria [1 ]
Marchetti, Paolo [1 ]
机构：
[1] Sapienza Univ, Div Oncol, St Andrea Hosp, Rome, Italy
来源：
ANTICANCER RESEARCH | 2017年 / 37卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
57
引用
收藏
页码：2084 / 2085
页数：2
相关论文
共 50 条
  • [21] A prognostic score for patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post chemotherapy
    Templeton, Arnoud J.
    Omlin, Aurelius Gabriel
    Pezaro, Carmel Jo
    Kheoh, Thian San
    Leibowitz-Amit, Raya
    Vera-Badillo, Francisco Emilio
    Tannock, Ian
    Attard, Gerhardt
    Amir, Eitan
    De Bono, Johann Sebastian
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [22] The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancer
    Boerrigter, Emmy
    Benoist, Guillemette E.
    Overbeek, Joanneke K.
    Donders, Rogier
    Mehra, Niven
    van Oort, Inge M.
    Ter Heine, Rob
    van Erp, Nielka P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1170 - 1178
  • [23] Abiraterone in the treatment of metastatic castration-resistant prostate cancer
    Mostaghel, Elahe A.
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 39 - 51
  • [24] A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer
    McKay, Rana R.
    Werner, Lillian
    Jacobus, Susanna J.
    Jones, Xandra
    Mostaghel, Elahe A.
    Marck, Brett T.
    Choudhury, Atish D.
    Pomerantz, Mark M.
    Sweeney, Christopher J.
    Slovin, Susan F.
    Morris, Michael J.
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    CANCER, 2019, 125 (04) : 524 - 532
  • [25] Abiraterone AcetateIn Metastatic Castration-Resistant Prostate Cancer
    Lily P. H. Yang
    Drugs, 2011, 71 : 2067 - 2077
  • [26] Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy
    Dupuy, Laura
    Long, Jerome
    Ranchoup, Yves
    CASE REPORTS IN ONCOLOGY, 2013, 6 (02): : 325 - 330
  • [27] Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
    Leibowitz-Amit, R.
    Templeton, A. J.
    Omlin, A.
    Pezaro, C.
    Atenafu, E. G.
    Keizman, D.
    Vera-Badillo, F.
    Seah, J. -A.
    Attard, G.
    Knox, J. J.
    Sridhar, S. S.
    Tannock, I. F.
    de Bono, J. S.
    Joshua, A. M.
    ANNALS OF ONCOLOGY, 2014, 25 (03) : 657 - 662
  • [28] Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer
    Lewis, Akeem R.
    Costello, Brian A.
    Quevedo, Fernando
    Pagliaro, Lance C.
    Sanhueza, Cristobal
    Weinshilboum, Richard M.
    Kalari, Krishna R.
    Wang, Liewei
    Kohli, Manish
    Tan, Winston
    Giridhar, Karthik V.
    PROSTATE, 2023, 83 (07): : 649 - 655
  • [29] Evaluation of factors predicting response to abiraterone acetate in metastatic castration-resistant prostate cancer: A prospective study
    Kumawat, Ghanshyam
    Yadav, S. S.
    Jaiswal, Sanjeev
    Sahu, Ramdayal
    Garg, Anurag
    Tomar, Vinay
    JOURNAL OF CLINICAL UROLOGY, 2024, 17 (04) : 386 - 394
  • [30] Abiraterone Acetate: A Review in Metastatic Castration-Resistant Prostrate Cancer
    Scott, Lesley J.
    DRUGS, 2017, 77 (14) : 1565 - 1576
12345